Myocardial Fibrosis Linked to Ventricular Arrhythmia in Male Endurance Athletes

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 22, 2025.

via HealthDay

TUESDAY, July 22, 2025 -- Myocardial fibrosis is independently associated with the onset of ventricular arrhythmia in male veteran endurance athletes, according to a study published online July 17 in Circulation: Cardiovascular Imaging.

Wasim Javed, Ph.D., from the University of Leeds/Leeds Teaching Hospitals National Health Service Trust in the United Kingdom, and colleagues conducted a prospective observational cohort study involving 106 asymptomatic male competitive cyclists/triathletes (aged 50 years and older) who undertook ≥10 hours/week of exercise over 15 years or more to examine whether myocardial fibrosis on cardiovascular magnetic resonance is associated with incident ventricular arrhythmia.

The researchers found that on cardiovascular magnetic resonance, 47.2 percent of athletes had focal myocardial fibrosis (all nonischemic distribution), predominantly affecting the basal inferolateral left ventricular segment. During follow-up (median, 720 days), 21.7 percent of athletes experienced one or more ventricular arrhythmic episodes: 2.8 percent had sustained ventricular tachycardia, and 18.9 percent had nonsustained ventricular tachycardia. An increased risk for incident ventricular arrhythmia was seen in association with myocardial fibrosis and greater left ventricular end-diastolic volume indexed (hazard ratios, 4.7 and 1.4, respectively), but there was no association for right ventricular insertion point late gadolinium enhancement. After adjustment for left ventricular end-diastolic volume indexed, myocardial fibrosis remained predictive (hazard ratio, 4.7).

"After adjusting for left ventricular dilatation, which to a lesser extent was also associated with ventricular arrhythmia, fibrosis remained significantly associated with ventricular arrhythmia," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-23 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords